Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model

[1]  M. Wong.  Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations , 2013, Experimental Neurology.

[2]  Bernardo L. Sabatini,et al.  Excitatory/Inhibitory Synaptic Imbalance Leads to Hippocampal Hyperexcitability in Mouse Models of Tuberous Sclerosis , 2013, Neuron.

[3]  J. Babb,et al.  Brain MR spectroscopic abnormalities in “MRI-negative” tuberous sclerosis complex patients , 2013, Epilepsy & Behavior.

[4]  M. Mizuguchi,et al.  Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex , 2012, Nature Communications.

[5]  S. Lazic,et al.  A call for transparent reporting to optimize the predictive value of preclinical research , 2012, Nature.

[6]  D. Feldmeyer.  Excitatory neuronal connectivity in the barrel cortex , 2012, Front. Neuroanat..

[7]  E. Klann,et al.  Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin , 2012, Neurobiology of Disease.

[8]  Doug W. Smith,et al.  An Emerging Role for the Mammalian Target of Rapamycin in “Pathological” Protein Translation: Relevance to Cocaine Addiction , 2011, Front. Pharmacol..

[9]  Jessica A. Cardin,et al.  A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior , 2011, Molecular Psychiatry.

[10]  S. Schachter,et al.  The NMDA receptor complex as a therapeutic target in epilepsy: a review , 2011, Epilepsy & Behavior.

[11]  J. Snyder,et al.  Mechanism for Noncompetitive Inhibition by Novel GluN2C/D N-Methyl-d-aspartate Receptor Subunit-Selective Modulators , 2011, Molecular Pharmacology.

[12]  M. Sahin,et al.  TSC1/TSC2 signaling in the CNS , 2011, FEBS letters.

[13]  J. Platel,et al.  Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. , 2011, The Journal of clinical investigation.

[14]  P. Crino,et al.  mTOR and epileptogenesis in developmental brain malformations , 2010 .

[15]  B. Taillon,et al.  Analysis of TSC Cortical Tubers by Deep Sequencing of TSC1, TSC2 and KRAS Demonstrates that Small Second‐Hit Mutations in these Genes are Rare Events , 2010, Brain pathology.

[16]  E. Aronica,et al.  Biallelic TSC gene inactivation in tuberous sclerosis complex , 2010, Neurology.

[17]  S. Camposano,et al.  The natural history of epilepsy in tuberous sclerosis complex , 2009, Epilepsia.

[18]  Mustafa Sahin,et al.  Tsc2-Rheb Signaling Regulates EphA-Mediated Axon Guidance , 2009, Nature Neuroscience.

[19]  D. Jane,et al.  N-Methyl-d-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse , 2009, Journal of Pharmacology and Experimental Therapeutics.

[20]  D. Pinault,et al.  NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness , 2009, PloS one.

[21]  John R. Huguenard,et al.  Neurons that Fire Together Also Conspire Together: Is Normal Sleep Circuitry Hijacked to Generate Epilepsy? , 2009, Neuron.

[22]  L. Kornreich,et al.  Unusual Clinical Presentation of Tuberless Tuberous Sclerosis Complex , 2009, Journal of child neurology.

[23]  E. Thiele,et al.  Role of mutational analysis in diagnosis of tuberous sclerosis complex , 2009, Clinical genetics.

[24]  C. Petersen,et al.  The Excitatory Neuronal Network of the C2 Barrel Column in Mouse Primary Somatosensory Cortex , 2009, Neuron.

[25]  M. Gambello,et al.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse , 2009, Human molecular genetics.

[26]  Mirela V. Simon,et al.  Are cortical tubers epileptogenic? Evidence from electrocorticography , 2009, Epilepsia.

[27]  Alcino J. Silva,et al.  Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis , 2008, Nature Medicine.

[28]  Mustafa Sahin,et al.  Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function , 2008, The Journal of Neuroscience.

[29]  F. Jensen,et al.  Cell‐specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers , 2008, Annals of neurology.

[30]  D. Gutmann,et al.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex , 2008, Annals of neurology.

[31]  J. Cheadle,et al.  Cognitive deficits in Tsc1+/−mice in the absence of cerebral lesions and seizures , 2007, Annals of neurology.

[32]  John R. Huguenard,et al.  Thalamic synchrony and dynamic regulation of global forebrain oscillations , 2007, Trends in Neurosciences.

[33]  F. Jensen,et al.  A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival , 2007, The Journal of Neuroscience.

[34]  E. Aronica,et al.  Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly , 2007, Acta Neuropathologica.

[35]  A. V. van Huffelen,et al.  Epilepsy Surgery in Tuberous Sclerosis: A Systematic Review , 2007, Epilepsia.

[36]  E. Aronica,et al.  Differential Cellular Gene Expression in Ganglioglioma , 2007, Epilepsia.

[37]  Ann Marie Craig,et al.  NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo , 2007, The Journal of Neuroscience.

[38]  P. Crino.  Focal brain malformations: a spectrum of disorders along the mTOR cascade. , 2007, Novartis Foundation symposium.

[39]  J. Swann,et al.  Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia , 2006, Annals of neurology.

[40]  P. Curatolo,et al.  Current management for epilepsy in tuberous sclerosis complex , 2006, Current opinion in neurology.

[41]  Michael J. Gutnick,et al.  NMDA Receptors in Layer 4 Spiny Stellate Cells of the Mouse Barrel Cortex Contain the NR2C Subunit , 2006, The Journal of Neuroscience.

[42]  Bernardo L Sabatini,et al.  Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2 , 2005, Nature Neuroscience.

[43]  T. Tamiya,et al.  A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism. , 2005, The Journal of molecular diagnostics : JMD.

[44]  C. Cepeda,et al.  Are Cytomegalic Neurons and Balloon Cells Generators of Epileptic Activity in Pediatric Cortical Dysplasia? , 2005, Epilepsia.

[45]  J. González-Martínez,et al.  The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia , 2005, Brain Research.

[46]  W. Hauser,et al.  Comment on Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) , 2005, Epilepsia.

[47]  C. Elger,et al.  Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) , 2005, Epilepsia.

[48]  Catherine Tallon-Baudry,et al.  The many faces of the gamma band response to complex visual stimuli , 2005, NeuroImage.

[49]  H. Vinters,et al.  Insulin signaling pathways in cortical dysplasia and TSC‐tubers: Tissue microarray analysis , 2004, Annals of neurology.

[50]  E. Aronica,et al.  mTOR cascade activation distinguishes tubers from focal cortical dysplasia , 2004, Annals of neurology.

[51]  R. Yuste,et al.  Thalamocortical Bursts Trigger Recurrent Activity in Neocortical Networks: Layer 4 as a Frequency-Dependent Gate , 2002, The Journal of Neuroscience.

[52]  H. Onda,et al.  Astrocyte‐specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures , 2002, Annals of neurology.

[53]  J. Krystal,et al.  Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. , 2002, Archives of general psychiatry.

[54]  C. Elger,et al.  Focal cortical dysplasia of Taylor's balloon cell type: Mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis , 2002, Annals of neurology.

[55]  P. Crino,et al.  Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia , 2001, Neurology.

[56]  Helen J. Cross,et al.  A Possible Role for Gap Junctions in Generation of Very Fast EEG Oscillations Preceding the Onset of, and Perhaps Initiating, Seizures , 2001, Epilepsia.

[57]  B. Scheithauer,et al.  Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers , 2001, Annals of neurology.

[58]  M Pastor,et al.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[59]  T. Babb,et al.  Epileptogenicity Correlated with Increased N‐Methyl‐d‐Aspartate Receptor Subunit NR2A/B in Human Focal Cortical Dysplasia , 2000, Epilepsia.

[60]  R. Köhling,et al.  Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: quantitative in vitro receptor autoradiography , 1999, Neuroscience.

[61]  J. Lübke,et al.  Reliable synaptic connections between pairs of excitatory layer 4 neurones within a single ‘barrel’ of developing rat somatosensory cortex , 1999, The Journal of physiology.

[62]  D. E. Clark,et al.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.

[63]  D. E. Clark.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.

[64]  Alexander M Binshtok,et al.  Functionally Distinct NMDA Receptors Mediate Horizontal Connectivity within Layer 4 of Mouse Barrel Cortex , 1998, Neuron.

[65]  B. Scheithauer,et al.  Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. , 1997, The American journal of pathology.

[66]  J. Kemp,et al.  Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. , 1997, The Journal of pharmacology and experimental therapeutics.

[67]  G Buzsáki,et al.  Cellular–Synaptic Generation of Sleep Spindles, Spike-and-Wave Discharges, and Evoked Thalamocortical Responses in the Neocortex of the Rat , 1997, The Journal of Neuroscience.

[68]  M. Flessner,et al.  Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. , 1997, Journal of the National Cancer Institute.

[69]  D. McCormick,et al.  Sleep and arousal: thalamocortical mechanisms. , 1997, Annual review of neuroscience.

[70]  B. Sakmann,et al.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.

[71]  D. Kwiatkowski,et al.  Tuberous sclerosis. , 1994, Archives of dermatology.

[72]  O. Dulac,et al.  Topographic Comparative Study of Magnetic Resonance Imaging and Electroencephalography in 34 Children with Tuberous Sclerosis , 1990, Epilepsia.